Monitoring

Substance-Related Disorders – Prevalence of Cases Identified Using Administrative Databases, 2001-2016

This report presents the annual and cumulative prevalence of substance-related disorders (SRDs). It demonstrates the ability of the Québec Integrated Chronic Disease Surveillance System (QICDSS) to allow for the study of SRDs based on health administrative databases. Prevalences were determined based on administrative data from April 1, 2001 to March 31, 2016, for all persons eligible for coverage by the Régie de l'assurance maladie du Québec and aged 12 and older. To be identified as having…

Monitoring report

Health services use and frailty among Québec seniors with a minor fracture

Principaux constats :

Among individuals aged 65 years and older having suffered a minor fracture, 13.6% were considered frail while 5.2% were robust. This study shows that frail elderly seniors use health care more extensively after experiencing a minor fracture. It is possible to characterize seniors’ frailty status at a population level using an adaptation of a frailty index in the healthcare administrative databases.
Monitoring report

Portrait of Preterm and Small-for-Gestational-Age Birth by Linguistic Community in Québec, 1989 to 2010

This surveillance report examines changes from 1989–1992 to 2008–2010 in preterm and small-for-gestational-age birth rates in Québec for the general population and by mother’s first language. Rates based on selected sociodemographic characteristics (e.g., place of residence, material deprivation, and immigrant status) of mothers in each linguistic community are also presented.

The report’s main finding is that previously observed variations in perinatal health favoring Anglophones…

Monitoring report

Autism Spectrum Disorder Surveillance in Québec

This report discusses the prevalence and the incidence rate of autism spectrum disorder (ASD). It also demonstrates the capability of the Québec Integrated Chronic Disease Surveillance System (QICDSS) to identify the comorbidities associated with ASD and the profile of health services utilization. These estimates were obtained from a longitudinal study covering the period from April 1, 2000, to March 31, 2015, for all persons eligible for health coverage between the ages of 1…

Monitoring report

Vascular Access–Related Bloodstream Infections in Hemodialysis Patients Surveillance results: 2016-2017

From April 1st, 2016, to March 31st, 2017, 48 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 57,570 patient-periods (Table 1). Participating units reported 127 VARBSIs in 120 patients. Patient-periods involving a fistula account for 40.7% of patient-periods. The VARBSI incidence rate is 0.06 cases per 100…

Monitoring report

Central Line–Associated Bloodstream Infections in Intensive Care Units Surveillance results: 2016-2017

From April 1st, 2016, to March 31st, 2017, 69 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 135,114 catheter days (Table 1). Participating ICUs report 133 CLABSIs in 125 patients. Incidence rates are 0.91 per 1,000 catheter days in coronary ICUs, 0.62 in teaching adult ICUs, 0.46 in non-teaching adult ICUs, 2.16 in pediatric ICUs and…

Monitoring report

Hospital-Wide Healthcare-associated Bloodstream Infections Surveillance results: 2016-2017

From April 1st, 2016, to March 31st, 2017, 89 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,830,348 patient days (Table 1). Participating facilities reported 3,167 BSIs in 2,982 patients. The total incidence rate was 5.43 cases per 10,000 patient days. The incidence rate in 2016–2017 is stable compared with the average rate for 2012–2016…

Monitoring report

Clostridium difficile–Associated Diarrhea Surveillance results: 2016-2017

From April 1st, 2016 to March 31st, 2017, 95 healthcare facilities participated in the Clostridium difficile–associated diarrhea (CDAD) surveillance program, for a combined total of 5,022,104 patient days (Table 1). These participating facilities reported 2,330 healthcare-associated CDAD (HA-CDAD), either acquired during a current or previous hospitalization (categories 1a and 1b). The HA-CDAD incidence rate was 4.64 …

Monitoring report

Carbapenemase-Producing Gram Negative Bacilli Infections Surveillance results: 2016-2017

From April 1st, 2016, to March 31st, 2017, 82 healthcare facilities took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 4,448,999 patient days (Table 1). These facilities reported 17 healthcare-associated CPGNB (HA-CPGNB) infections among patients who acquired their strain during a current or previous hospitalization (categories 1a and 1b). The incidence rate of HA-CPGNB infection was 0.04 per 10,000 patient…

Monitoring report

Vancomycin-Resistant Enterococci Infections Surveillance results: 2016-2017

From April 1st, 2016 to March 31st, 2017, 89 healthcare facilities took part in the surveillance of vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,827,659 patient days (Table 1). These facilities reported 44 healthcare-associated VRE (HA-VRE) infections, either acquired during a current or previous hospitalization (categories 1a and 1b). The HA-VRE infection rate was 0.09 per 10,000 patient days. This incidence rate was down from 2015…

Monitoring report